This company listing is no longer active
Acasti Pharma Balance Sheet Health
Financial Health criteria checks 5/6
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$31.26m |
Equity | US$96.72m |
Total liabilities | US$20.08m |
Total assets | US$116.80m |
Financial Position Analysis
Short Term Liabilities: ACST's short term assets ($33.4M) exceed its short term liabilities ($3.4M).
Long Term Liabilities: ACST's short term assets ($33.4M) exceed its long term liabilities ($16.6M).
Debt to Equity History and Analysis
Debt Level: ACST is debt free.
Reducing Debt: ACST has no debt compared to 5 years ago when its debt to equity ratio was 13.6%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ACST has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if ACST has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.